Cargando…

Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia

Metabotropic glutamate (mGlu) receptors are considered as candidate drug targets for the treatment of schizophrenia. These receptors form a family of eight subtypes (mGlu1 to −8), of which mGlu1 and −5 are coupled to G(q/11), and all other subtypes are coupled to G(i/o). Here, we discuss the possibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nicoletti, Ferdinando, Orlando, Rosamaria, Di Menna, Luisa, Cannella, Milena, Notartomaso, Serena, Mascio, Giada, Iacovelli, Luisa, Matrisciano, Francesco, Fazio, Francesco, Caraci, Filippo, Copani, Agata, Battaglia, Giuseppe, Bruno, Valeria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413697/ https://www.ncbi.nlm.nih.gov/pubmed/30890967 http://dx.doi.org/10.3389/fpsyt.2019.00049

Ejemplares similares

mGlu1 Receptors Monopolize the Synaptic Control of Cerebellar Purkinje Cells by Epigenetically Down-Regulating mGlu5 Receptors
por: Notartomaso, Serena, et al.
Publicado: (2018)

mGlu3 receptor regulates microglial cell reactivity in neonatal rats
por: Zinni, Manuela, et al.
Publicado: (2021)

Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1
por: Notartomaso, Serena, et al.
Publicado: (2013)

mGlu2 metabotropic glutamate receptors restrain inflammatory pain and mediate the analgesic activity of dual mGlu2/mGlu3 receptor agonists
por: Zammataro, Magda, et al.
Publicado: (2011)

Changes in mGlu5 Receptor Signaling Are Associated with Associative Learning and Memory Extinction in Mice
por: Teleuca, Ana Elena, et al.
Publicado: (2022)

In Vivo Non-radioactive Assessment of mGlu5 Receptor-Activated Polyphosphoinositide Hydrolysis in Response to Systemic Administration of a Positive Allosteric Modulator
por: Zuena, Anna R., et al.
Publicado: (2018)

Targeting mGlu5 Metabotropic Glutamate Receptors in the Treatment of Cognitive Dysfunction in a Mouse Model of Phenylketonuria
por: Nardecchia, Francesca, et al.
Publicado: (2018)

Targeting mGlu1 Receptors in the Treatment of Motor and Cognitive Dysfunctions in Mice Modeling Type 1 Spinocerebellar Ataxia
por: Liberatore, Francesca, et al.
Publicado: (2022)

Developmental up-regulation of NMDA receptors in the prefrontal cortex and hippocampus of mGlu5 receptor knock-out mice
por: Imbriglio, Tiziana, et al.
Publicado: (2021)

Correction to: Developmental up-regulation of NMDA receptors in the prefrontal cortex and hippocampus of mGlu5 receptor knock-out mice
por: Imbriglio, Tiziana, et al.
Publicado: (2021)

mGlu3 Metabotropic Glutamate Receptors as a Target for the Treatment of Absence Epilepsy: Preclinical and Human Genetics Data
por: Celli, Roberta, et al.
Publicado: (2023)

Genetic Deletion of mGlu3 Metabotropic Glutamate Receptors Amplifies Ischemic Brain Damage and Associated Neuroinflammation in Mice
por: Mastroiacovo, Federica, et al.
Publicado: (2021)

Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia
por: Fazio, Francesco, et al.
Publicado: (2015)

Altered Expression and In Vivo Activity of mGlu5 Variant a Receptors in the Striatum of BTBR Mice: Novel Insights Into the Pathophysiology of Adult Idiopathic Forms of Autism Spectrum Disorders
por: Matrisciano, Francesco, et al.
Publicado: (2022)

Perineuronal nets are under the control of type-5 metabotropic glutamate receptors in the developing somatosensory cortex
por: Mascio, Giada, et al.
Publicado: (2021)

Structural insights into dimerization and activation of the mGlu2–mGlu3 and mGlu2–mGlu4 heterodimers
por: Wang, Xinwei, et al.
Publicado: (2023)

Genetic deletion of mGlu2 metabotropic glutamate receptors improves the short-term outcome of cerebral transient focal ischemia
por: Mastroiacovo, Federica, et al.
Publicado: (2017)

Optical control of pain in vivo with a photoactive mGlu(5) receptor negative allosteric modulator
por: Font, Joan, et al.
Publicado: (2017)

Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain
por: Notartomaso, Serena, et al.
Publicado: (2017)

Correction: Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator
por: Font, Joan, et al.
Publicado: (2018)

Induction of the Wnt Antagonist Dickkopf-1 Is Involved in Stress-Induced Hippocampal Damage
por: Matrisciano, Francesco, et al.
Publicado: (2011)

N-Acetyl-cysteine causes analgesia by reinforcing the endogenous activation of type-2 metabotropic glutamate receptors
por: Bernabucci, Matteo, et al.
Publicado: (2012)

Activation of mGlu3 Receptors Stimulates the Production of GDNF in Striatal Neurons
por: Battaglia, Giuseppe, et al.
Publicado: (2009)

Negative Allosteric Modulators of mGlu(7) Receptor as Putative Antipsychotic Drugs
por: Cieślik, Paulina, et al.
Publicado: (2018)

Preclinical evaluation of the antipsychotic potential of the mGlu2-positive allosteric modulator JNJ-40411813
por: Lavreysen, Hilde, et al.
Publicado: (2015)

Allosteric Modulators for mGlu Receptors
por: Gasparini, F, et al.
Publicado: (2007)

HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity
por: Kurita, Mitsumasa, et al.
Publicado: (2012)

Metabotropic Glutamate Receptors in Glial Cells: A New Potential Target for Neuroprotection?
por: Spampinato, Simona Federica, et al.
Publicado: (2018)

Analgesic Activity of Cinnabarinic Acid in Models of Inflammatory and Neuropathic Pain
por: Notartomaso, Serena, et al.
Publicado: (2022)

Decreased striatal dopamine in group II metabotropic glutamate receptor (mGlu2/mGlu3) double knockout mice
por: Lane, Tracy A, et al.
Publicado: (2013)

Emotional Impairment and Persistent Upregulation of mGlu(5) Receptor following Morphine Abstinence: Implications of an mGlu(5)-MOPr Interaction
por: Zanos, Panos, et al.
Publicado: (2016)

Design and Synthesis of New Quinazolin-4-one Derivatives with Negative mGlu(7) Receptor Modulation Activity and Antipsychotic-Like Properties
por: Kaczorowska, Katarzyna, et al.
Publicado: (2023)

mGlu5 Receptor Functional Interactions and Addiction
por: Brown, Robyn M., et al.
Publicado: (2012)

mGlu(5) Positive Allosteric Modulators Facilitate Long-Term Potentiation via Disinhibition Mediated by mGlu(5)-Endocannabinoid Signaling
por: Xiang, Zixiu, et al.
Publicado: (2019)

Control of Theta Oscillatory Activity Underlying Fear Expression by mGlu(5) Receptors
por: Matulewicz, Pawel, et al.
Publicado: (2022)

An Appraisal of the Influence of the Metabotropic Glutamate 5 (mGlu5) Receptor on Sociability and Anxiety
por: Ramos-Prats, Arnau, et al.
Publicado: (2019)

New 1,2,4-oxadiazole derivatives with positive mGlu(4) receptor modulation activity and antipsychotic-like properties
por: Stankiewicz, Anna, et al.
Publicado: (2021)

Neurobiological Insights from mGlu Receptor Allosteric Modulation
por: O’Brien, Daniel E, et al.
Publicado: (2015)

Exploring the Activation Mechanism of the mGlu5 Transmembrane Domain
por: Lans, Isaias, et al.
Publicado: (2020)

Regulation and functional consequences of mGlu(4) RNA editing
por: Hofmann, Christopher S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_reaf0se9qnh5f6sqac7a1h4eb8